Abell Foundation invests in eye scanner firm

February 24, 2016

The Abell Foundation announced Tuesday that it has invested $250,000 in Vasoptic Medical Inc., a Baltimore-based firm that’s developing a portable retinal imager to make it easier to monitor diabetes and diseases of the eye.

 

Vasoptic moved into Baltimore from Columbia in August after a $250,000 investment last year from Abell, which makes targeted venture-capital investments in firms to foster technology and research in the city. The foundation’s ultimate goal is to create jobs in Baltimore.

 

"Expanding our investment in Vasoptic Medical Inc. is a win-win for Baltimore," the Abell Foundation board said in a statement. "Vasoptic is growing Baltimore's innovative tech industry and is poised to improve access to affordable healthcare for low-income populations."

 

For full story click here.

Share on Facebook
Share on Twitter
Please reload

Recent News

Vasoptic Medical impresses at ARVO 2017

May 30, 2017

Vasoptic Medical's $1.5 million cash infusion pushes it toward FDA approval

April 24, 2017

Title: Ophthalmic examination and disease management with multiple illumination modalities

Patent No. US9492083

Vasoptic receives another patent issuance from The United States Patent and Trademark Office (USPTO)

November 15, 2016

1/10
Please reload

© 2019 Vasoptic Medical Inc.

1215 E. Fort Ave Suite 304
Baltimore, MD 21230